1066 — Shandong Weigao Medical Polymer Co Share Price
0.000.00%
Last trade - 00:00- HK$28.15bn
- HK$25.38bn
- CNY13.09bn
- 93
- 70
- 92
- 98
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 10.59 | ||
| PEG Ratio (f) | 1.17 | ||
| EPS Growth (f) | 9.94% | ||
| Dividend Yield (f) | 4.25% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.06 | ||
| Price to Tang. Book | 1.35 | ||
| Price to Free Cashflow | 11.72 | ||
| Price to Sales | 1.92 | ||
| EV to EBITDA | 6.67 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 9.51% | ||
| Return on Equity | 8.95% | ||
| Operating Margin | 20.85% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 11,622.34 | 13,208.94 | 13,747.47 | 13,229.45 | 13,087.07 | 14,401.26 | 15,538.7 | 4.74% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +12.97 | +17.06 | +13.6 | -29.34 | +3.03 | +11.04 | +8.35 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Shandong Weigao Group Medical Polymer Co Ltd is a China-based company principally engaged in the research and development, production and sale of medical device products. The Company operates its businesses through six segments. The Medical Device segment produces and sells clinical care, medical testing, anesthesia and surgical related products and other consumables. The Orthopaedic Products segment produces and sells orthopaedic products, including tissue repair product line. The Interventional Products segment produces and sells tumour and blood vessel interventional instruments. The Pharma Packaging Products segment produces and sells pre-filled syringes and flushing syringes. The Blood Management Products segment produces and sells blood collection, irradiation, storage, separation and sterilization products. The Others segment engages in finance lease and factoring business. The Company mainly operates its businesses in the domestic and overseas markets.
Directors
- Jing Long CHM (46)
- Rinan Cong CEO (40)
- Zhengpeng Tang NVC (50)
- Xuefeng Wu CFO
- Hong Feng Ju DGM (46)
- Miu Ling Wong SEC (52)
- Lin Chen NED (45)
- Xiaoming Lian NED (48)
- Ming Zhong Fu NID (70)
- Wai Hung Lo NID (61)
- Jin xia Wang NID (66)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 28th, 2000
- Public Since
- February 27th, 2004
- No. of Employees
- 12,719
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 4,564,947,924
- Address
- No.18 Xingshan Road, WEIHAI, 264210
- Web
- https://www.weigaoholding.com/
- Phone
- +86 6315621999
- Auditors
- Deloitte Touche Tohmatsu CPA
Upcoming Events for 1066
Shandong Weigao Group Medical Polymer Co Ltd Annual Shareholders Meeting
Dividend For 1066.HK - 0.1235 CNY
Half Year 2025 Shandong Weigao Group Medical Polymer Co Ltd Earnings Release
Similar to 1066
Acotec Scientific Holdings
Stock Exchange of Hong Kong Limited
Beijing Airdoc Technology Co
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
FAQ
What is the Shandong Weigao Medical Polymer Co share price?
As of Today at 24:04 UTC, shares in Shandong Weigao Medical Polymer Co are trading at HK$5.96. This share price information is delayed by 15 minutes.
How has the Shandong Weigao Medical Polymer Co share price performed this year?
Shares in Shandong Weigao Medical Polymer Co last closed at HK$5.96 and the price had moved by +13.09% over the past 365 days. In terms of relative price strength the Shandong Weigao Medical Polymer Co share price has outperformed the FTSE Developed Asia Pacific Index by +15.13% over the past year.
What are the analyst and broker recommendations for Shandong Weigao Medical Polymer Co?
The overall consensus recommendation for Shandong Weigao Medical Polymer Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Shandong Weigao Medical Polymer Co dividend yield?
The Shandong Weigao Medical Polymer Co dividend yield is 1.72% based on the trailing twelve month period.
Does Shandong Weigao Medical Polymer Co pay a dividend?
Last year, Shandong Weigao Medical Polymer Co paid a total dividend of CNY0.09, and it currently has a trailing dividend yield of 1.72%.Looking ahead, shares in Shandong Weigao Medical Polymer Co are due to go ex-dividend on 2025-06-02 and the next dividend pay date is 2025-07-11.
When does Shandong Weigao Medical Polymer Co next pay dividends?
Shandong Weigao Medical Polymer Co are due to go ex-dividend on 2025-06-02 and the next dividend pay date is 2025-07-11. The historic dividend yield on Shandong Weigao Medical Polymer Co shares is currently 1.72%.
How do I buy Shandong Weigao Medical Polymer Co shares?
To buy shares in Shandong Weigao Medical Polymer Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Shandong Weigao Medical Polymer Co?
As of the previous close price of HK$5.96, shares in Shandong Weigao Medical Polymer Co had a market capitalisation of HK$27.21bn.
Where are Shandong Weigao Medical Polymer Co shares listed?
Here are the trading details for Shandong Weigao Medical Polymer Co:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 1066
What kind of share is Shandong Weigao Medical Polymer Co?
Based on an overall assessment of its quality, value and momentum Shandong Weigao Medical Polymer Co is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Shandong Weigao Medical Polymer Co share price forecast for 2025?
The analyst consensus target price for shares in Shandong Weigao Medical Polymer Co is HK$6.42. That is 7.66% above the last closing price of HK$5.96.
Analysts covering Shandong Weigao Medical Polymer Co currently have a consensus Earnings Per Share (EPS) forecast of CNY0.50 for the next financial year.
Find out moreWhat is the trend in the Shandong Weigao Medical Polymer Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Shandong Weigao Medical Polymer Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +30.06%.
As of the last closing price of HK$5.96, shares in Shandong Weigao Medical Polymer Co were trading +22.15% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Shandong Weigao Medical Polymer Co PE Ratio?
The Shandong Weigao Medical Polymer Co PE ratio based on its reported earnings over the past 12 months is 10.59. The shares last closed at HK$5.96.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Shandong Weigao Medical Polymer Co?
Shandong Weigao Medical Polymer Co's management team is headed by:
- Jing Long - CHM
- Rinan Cong - CEO
- Zhengpeng Tang - NVC
- Xuefeng Wu - CFO
- Hong Feng Ju - DGM
- Miu Ling Wong - SEC
- Lin Chen - NED
- Xiaoming Lian - NED
- Ming Zhong Fu - NID
- Wai Hung Lo - NID
- Jin xia Wang - NID